Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.3MFederal grants as PI4 awards
3Patents grantedLatest Sep 9, 2025
267Papers9,574 citations
Federal awards and patents by year
AwardsPatents
4 awards · $3.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 25, 2016 | NIH | SBIR Phase II Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma | $966K | Altor BioScience, LLC |
| Sep 22, 2015 | NIH | SBIR Phase II Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma | $962K | Altor BioScience, LLC |
| Jul 22, 2015 | NIH | SBIR Phase II Novel IL-15 Superagonist Therapy for Bladder Cancer | $598K | Altor BioScience, LLC |
| Jul 1, 2015 | NIH | SBIR Phase II IL-15 Superagonist Complex as an Immunotherapeutic for Multiple Myeloma | $750K | Altor BioScience, LLC |
4 patents as inventor
- US 12168680Altor BioScience, LLCDec 17, 2024
- US 12371472Altor BioScience, LLCJul 29, 2025
- US 12410224Altor BioScience, LLCSep 9, 2025
- US Altor BioScience, LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#541
Awards as PI#566
Patents#63
Companies
- Altor BioScience, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.